KETALAR DIN 00224391
Status: Marketed
Holder: SEARCHLIGHT PHARMA INC
Molecule: KETAMINE (KETAMINE HYDROCHLORIDE)
Available to quote
Health Canada record
| Active ingredient(s) | KETAMINE (KETAMINE HYDROCHLORIDE) 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Intravenous |
| Schedule | NARCOTICS (CDSA I) |
| Class | Human |
| ATC | N01AX03 KETAMINE |
| Original market date | 31-Dec-1972 |
| Current status date | 16-Oct-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Searchlight Pharma Inc — licence 102247, currently licensed, last inspection rating C (2024-10-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing KETAMINE (KETAMINE HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00224405 | KETALAR | SEARCHLIGHT PHARMA INC | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 50 MG | Marketed |
| 02470950 | KETAMINE HYDROCHLORIDE INJECTION USP | STERIMAX INC | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 500 MG | Approved |
| 02470934 | KETAMINE HYDROCHLORIDE INJECTION USP | STERIMAX INC | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 100 MG | Approved |
| 02246795 | KETAMINE HYDROCHLORIDE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 10 MG | Marketed |
| 02246796 | KETAMINE HYDROCHLORIDE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 50 MG | Marketed |
| 02550458 | KETAMINE HYDROCHLORIDE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 50 MG | Marketed |
| 02550431 | KETAMINE HYDROCHLORIDE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 10 MG | Marketed |
| 02525836 | KETAMINE INJECTION, BP | BAXTER CORPORATION | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 50 MG | Approved |
| 02535645 | KETAMINE INJECTION, BP | STERIMAX INC | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 50 MG | Marketed |
| 02173239 | KETASET | ZOETIS CANADA INC | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 100 MG | Marketed |
| 02374994 | NARKETAN | VETOQUINOL N A INC | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 100 MG | Marketed |
| 02534576 | ANESKETIN | EUROVET ANIMAL HEALTH B.V. | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 100 MG | Dormant |
| 00612316 | KETALEAN | BIMEDA-MTC ANIMAL HEALTH INC | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 100 MG | Dormant |
| 02387301 | KETAMINE HYDROCHLORIDE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 10 MG | Cancelled Pre Market |
| 02387328 | KETAMINE HYDROCHLORIDE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 50 MG | Cancelled Pre Market |
| 02387336 | KETAMINE HYDROCHLORIDE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 50 MG | Cancelled Post Market |
| 02257920 | KETAMINE HYDROCHLORIDE INJECTION USP | SABEX INC | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 100 MG | Cancelled Pre Market |
| 00844276 | KETASET INJ 100MG/ML | AYERST LABORATORIES | Liquid | KETAMINE (KETAMINE HYDROCHLORIDE) 100 MG | Cancelled Post Market |
| 00170534 | ROGARSETIC INJECTION | PFIZER CANADA INC ANIMAL HEALTH GROUP | Liquid | KETAMINE (KETAMINE HYDROCHLORIDE) 100 MG | Cancelled Post Market |
| 01989529 | VETALAR | VETOQUINOL N A INC | Solution | KETAMINE (KETAMINE HYDROCHLORIDE) 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 30819 | 2023-05-24 | New Drug Submission (NDS) | Administrative: Change in Product Ownership |
| 24399 | 2020-10-08 | Supplement to a New Drug Submission (SNDS) | RESPONSE TO ADVISEMENT LETTER |
| 7236 | 2005-07-12 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 2358 | 2001-01-18 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |